Image
National News

Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge

FILE — Pfizer-BioNTech, left, and Moderna COVID-19 doses ready for patients at Cornerstone Pharmacy in Little Rock, Ark., on March 8, 2021. In a half-dozen studies published over the past few weeks, Moderna’s vaccine appeared to be more protective over the long term than the Pfizer-BioNTech vaccine. (Rory Doyle/The New York Times)